CHEK2 and breast carcinoma: The CHEK2 1100*delC, a truncating variant that impairs the kinase activity of the protein, is associated with an increase of BC risk in BRCA1/2-negative individuals with a family history (The CHEK2-Breast Cancer Consortium., 2002; Vahteristo et al, 2002).